申请人:TANABE SEIYAKU CO., LTD.
公开号:EP0363061A1
公开(公告)日:1990-04-11
Imidazoline derivative of the formula:
wherein R is a halogenophenyl group or a pyridyl group and X¹ and X² are a hydrogen atom or a lower alkoxy group, or a pharmaceutically acceptable salt thereof, which is useful as an immunomodulator and as an agent for the treatment and/or prophylaxis of rheumathoid arthritis, multiple sclerosis, systemic lupus erythemathodes, rheumatic fever and the like, a process for the preparation thereof, and a pharmaceutical composition containing said compound as an active ingredient.
式中的咪唑啉衍生物:
其中 R 为卤代苯基或吡啶基,X¹ 和 X² 为氢原子或低级烷氧基,或其药学上可接受的盐,可用作免疫调节剂,以及治疗和/或预防类风湿性关节炎、多发性硬化症、系统性红斑狼疮、风湿热等疾病的药物,其制备方法,以及含有上述化合物作为活性成分的药物组合物。